Conceptual, Regulatory and Strategic Imperatives in the Early Days of EEG-Based Biomarker Validation for Neurodevelopmental Disabilities

por Ewen, Joshua B., Sweeney, John A., Potter, William Z.
Publicado 2019

Imaging as a biomarker in drug discovery for Alzheimer’s disease: is MRI a suitable technology?

por Merlo Pich, Emilio, Jeromin, Andreas, Frisoni, Giovanni B, Hill, Derek, Lockhart, Andrew, Schmidt, Mark E, Turner, Martin R, Mondello, Stefania, Potter, William Z
Publicado 2014

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

por Mattsson, Niklas, Carrillo, Maria C., Dean, Robert A., Devous, Michael D., Nikolcheva, Tania, Pesini, Pedro, Salter, Hugh, Potter, William Z., Sperling, Reisa S., Bateman, Randall J., Bain, Lisa J., Liu, Enchi
Publicado 2015

Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease

por Libiger, Ondrej, Shaw, Leslie M., Watson, Mark H., Nairn, Angus C., Umaña, Kelly L., Biarnes, Michael C., Canet‐Avilés, Rosa M., Jack, Clifford R., Breton, Yannick‐André, Cortes, Laetitia, Chelsky, Daniel, Spellman, Daniel S., Baker, Susan A., Raghavan, Nandini, Potter, William Z.
Publicado 2021

Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharm...

por Kantrowitz, Joshua T., Grinband, Jack, Goff, Donald C., Lahti, Adrienne C., Marder, Stephen R., Kegeles, Lawrence S., Girgis, Ragy R., Sobeih, Tarek, Wall, Melanie M., Choo, Tse-Hwei, Green, Michael F., Yang, Yvonne S., Lee, Junghee, Horga, Guillermo, Krystal, John H., Potter, William Z., Javitt, Daniel C., Lieberman, Jeffrey A.
Publicado 2020

A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms

por Fleming, Leah M., Javitt, Daniel C., Carter, Cameron S., Kantrowitz, Joshua T., Girgis, Ragy R., Kegeles, Lawrence S., Ragland, John D., Maddock, Richard J., Lesh, Tyler A., Tanase, Costin, Robinson, James, Potter, William Z., Carlson, Marlene, Wall, Melanie M., Choo, Tse-Hwei, Grinband, Jack, Lieberman, Jeffrey, Krystal, John H., Corlett, Philip R.
Publicado 2019

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid

por Hendrickson, Ronald C., Lee, Anita Y. H., Song, Qinghua, Liaw, Andy, Wiener, Matt, Paweletz, Cloud P., Seeburger, Jeffrey L., Li, Jenny, Meng, Fanyu, Deyanova, Ekaterina G., Mazur, Matthew T., Settlage, Robert E., Zhao, Xuemei, Southwick, Katie, Du, Yi, Holder, Dan, Sachs, Jeffrey R., Laterza, Omar F., Dallob, Aimee, Chappell, Derek L., Snyder, Karen, Modur, Vijay, King, Elizabeth, Joachim, Catharine, Bondarenko, Andrey Y., Shearman, Mark, Soper, Keith A., Smith, A. David, Potter, William Z., Koblan, Ken S., Sachs, Alan B., Yates, Nathan A.
Publicado 2015